125720-84-5
中文名称
125720-84-5
英文名称
1-[2-(2-Propenyl)phenoxy]-3-isopropylaminoacetone (E)-oxime
CAS
125720-84-5
分子式
C15H22N2O2
分子量
262.35
MOL 文件
125720-84-5.mol
结构式
基本信息
中文别名
化合物 T10001
英文别名
CDDD-1815
(E)-Alprenoxime
1-[2-(2-Propenyl)phenoxy]-3-isopropylaminoacetone (E)-oxime
2-Propanone, 1-[(1-methylethyl)amino]-3-[2-(2-propenyl)phenoxy]-, oxime, (E)- (9CI)
(E)-Alprenoxime
1-[2-(2-Propenyl)phenoxy]-3-isopropylaminoacetone (E)-oxime
2-Propanone, 1-[(1-methylethyl)amino]-3-[2-(2-propenyl)phenoxy]-, oxime, (E)- (9CI)
物理化学性质
| 沸点 | 398.7±37.0 °C(Predicted) |
| 密度 | 1.02±0.1 g/cm3(Predicted) |
| 储存条件 | -20°C储存 |
| 溶解度 | 溶于二甲基亚砜 |
| 酸度系数(pKa) | 11.41±0.10(Predicted) |
常见问题列表
生物活性
(E)-Alprenoxime 是 Alprenoxime 的异构体。Alprenoxime 是一种位点活化的 β 阻断剂。
靶点
β blocker
体内研究
The purpose of the present study is to explore the pharmacological significance of Alprenoxime peripheral /βblocking activity in a non-rodent animal model. Interspecies scaling considerations predict that the doses selected in this study (1 and 5 mg/kg) are pharmacologically comparable or greater than doses used in rodent studies (2 and 6 mg/kg). More importantly, the prolonged ocular antihypertensive effects that are shown with 1% ophthalmic solutions indicate that the i.v. dose tested in the present study is likely to be more than two orders of magnitude greater than probable therapeutic doses.